FDA Inspection 920619 — Dan A. Waxman, M.D.
The FDA completed an inspection of Dan A. Waxman, M.D. on Apr 2, 2015 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 2, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Indianapolis, IN (United States)
Additional Details
Clinical Investigator (CI)